{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:35:16Z","timestamp":1778934916967,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1239-8","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T13:03:04Z","timestamp":1550149384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft"],"prefix":"10.1186","volume":"20","author":[{"given":"Jon","family":"Von Visger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa","family":"Cassol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uday","family":"Nori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Franco-Ahumada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Nadasdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-0161","authenticated-orcid":false,"given":"Anjali A.","family":"Satoskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"1239_CR1","doi-asserted-by":"crossref","unstructured":"Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol : JASN. 2009;20(9):2055\u20132064. PubMed PMID: 19470674. Pubmed Central PMCID: 2736767.","DOI":"10.1681\/ASN.2009010110"},{"issue":"4","key":"1239_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ki.2014.408","volume":"87","author":"F Bridoux","year":"2015","unstructured":"Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand JP, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87(4):698\u2013711 PubMed PMID: 25607108.","journal-title":"Kidney Int"},{"issue":"22","key":"1239_CR3","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","volume":"120","author":"N Leung","year":"2012","unstructured":"Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, et al. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012;120(22):4292\u20135 PubMed PMID: 23047823.","journal-title":"Blood"},{"key":"1239_CR4","doi-asserted-by":"crossref","unstructured":"Nasr SH, Sethi S, Cornell LD, Fidler ME, Boelkins M, Fervenza FC, et al. Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft. Clin J Am Soc Nephrol : CJASN. 2011;6(1):122\u2013132. PubMed PMID: 20876681. Pubmed Central PMCID: 3022233.","DOI":"10.2215\/CJN.05750710"},{"key":"1239_CR5","doi-asserted-by":"crossref","unstructured":"Albawardi A, Satoskar A, Von Visger J, Brodsky S, Nadasdy G, Nadasdy T. Proliferative glomerulonephritis with monoclonal IgG deposits recurs or may develop de novo in kidney allografts. Am J Kidney Dis 2011;58(2):276\u2013281. PubMed PMID: 21705124.","DOI":"10.1053\/j.ajkd.2011.05.003"},{"issue":"7","key":"1239_CR6","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2215\/CJN.10611110","volume":"6","author":"E Guiard","year":"2011","unstructured":"Guiard E, Karras A, Plaisier E, Duong Van Huyen JP, Fakhouri F, Rougier JP, et al. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab. Clin J Am Soc Nephrol. 2011;6(7):1609\u201316 PubMed PMID: 21700823.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"1239_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/ajh.23798","volume":"89","author":"M Perry","year":"2014","unstructured":"Perry M, Delarche A, Ribes D, Vergez F, Guilbeau-Frugier C, Laurent C, et al. Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas. Am J Hematol. 2014;89(10):969\u201373 PubMed PMID: 25043930.","journal-title":"Am J Hematol"},{"issue":"9","key":"1239_CR8","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2215\/CJN.03160316","volume":"11","author":"JJ Hogan","year":"2016","unstructured":"Hogan JJ, Weiss BM. Bridging the divide: an Onco-Nephrologic approach to the monoclonal Gammopathies of renal significance. Clin J Am Soc Nephrol. 2016;11(9):1681\u201391 PubMed PMID: 27416775. Pubmed Central PMCID: 5012477.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1239_CR9","doi-asserted-by":"publisher","unstructured":"Leung N, Nasr SH. Dysproteinemias and glomerular disease. Clin J Am Soc Nephrol ePress. 2017. https:\/\/doi.org\/10.2215\/CJN.00560117 .","DOI":"10.2215\/CJN.00560117"},{"issue":"5","key":"1239_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/PAS.0000000000000605","volume":"40","author":"J Hemminger","year":"2016","unstructured":"Hemminger J, Nadasdy G, Satoskar A, Brodsky SV, Nadasdy T. IgG subclass staining in routine renal biopsy material. Am J Surg Pathol. 2016;40(5):617\u201326 PubMed PMID: 26848798.","journal-title":"Am J Surg Pathol"},{"key":"1239_CR11","doi-asserted-by":"crossref","unstructured":"Beck LH, Jr., Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol : JASN. 2011;22(8):1543\u20131550. PubMed PMID: 21784898. Pubmed Central PMCID: 3148709.","DOI":"10.1681\/ASN.2010111125"},{"key":"1239_CR12","doi-asserted-by":"crossref","unstructured":"Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, et al. Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up. J Am Soc Nephrol : JASN. 2017;28(1):348\u2013358. PubMed PMID: 27352623. Pubmed Central PMCID: 5198292.","DOI":"10.1681\/ASN.2016040449"},{"issue":"5","key":"1239_CR13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1681\/ASN.V125919","volume":"12","author":"HJ Anders","year":"2001","unstructured":"Anders HJ, Vielhauer V, Kretzler M, Cohen CD, Segerer S, Luckow B, et al. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J Am Soc Nephrol. 2001;12(5):919\u201331 PubMed PMID: 11316850.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1239_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1006\/exmp.2000.2330","volume":"69","author":"JM Cruse","year":"2000","unstructured":"Cruse JM, Lewis RE, Dilioglou S. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL\/Mp lpr\/lpr mice. Exp Mol Pathol. 2000;69(3):211\u201322 PubMed PMID: 11115362.","journal-title":"Exp Mol Pathol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1239-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1239-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1239-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T21:47:19Z","timestamp":1662932839000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1239-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1239"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1239-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"21 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ohio State University Office of responsible research practices IRB 2011H0364.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"53"}}